TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?

TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?

Transactivation response DNA binding protein 43 kDa (TDP-43) and tau are major pathological proteins of neurodegenerative disorders, of which neuronal and glial aggregates are pathological hallmarks. Interestingly, accumulating evidence from neuropathological studies has shown that comorbid TDP-43 p...

Full description

Bibliographic Details
Main Authors:	Yuichi Riku, Mari Yoshida, Yasushi Iwasaki, Gen Sobue, Masahisa Katsuno, Shinsuke Ishigaki
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	International Journal of Molecular Sciences
Subjects:	AD ALS CBD FTLD LATE PART
Online Access:	https://www.mdpi.com/1422-0067/23/24/15755

Similar Items

Pathway from TDP-43-Related Pathology to Neuronal Dysfunction in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration
by: Yuichi Riku, et al.
Published: (2021-04-01)

The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons
by: Daiyu Honda, et al.
Published: (2014-01-01)

Nuclear Expression of TDP-43 Is Linked with Morphology and Ubiquitylation of Cytoplasmic Aggregates in Amyotrophic Lateral Sclerosis
by: Hiroyuki Yabata, et al.
Published: (2023-07-01)

Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies
by: Yohei Iguchi, et al.
Published: (2012-03-01)

HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP‐43 proteinopathies
by: Cheng‐Chun Wu, et al.
Published: (2020-06-01)

TDP-43 Proteinopathies: A New Player in Neurodegenerative Diseases with Defective Protein Folding
by: Suna Lahut, et al.
Published: (2012-03-01)

TDP-43 Proteinopathies: A New Player in Neurodegenerative Diseases with Defective Protein Folding
by: Suna Lahut, et al.
Published: (2012-03-01)

Importance of Functional Loss of FUS in FTLD/ALS
by: Shinsuke Ishigaki, et al.
Published: (2018-05-01)

Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology
by: Yuan Tian, et al.
Published: (2021-12-01)

Parkin beyond Parkinson’s Disease—A Functional Meaning of Parkin Downregulation in TDP-43 Proteinopathies
by: Katarzyna Gaweda-Walerych, et al.
Published: (2021-12-01)

A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects
by: Simona Langellotti, et al.
Published: (2016-06-01)

Altered Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes
by: Shinsuke Ishigaki, et al.
Published: (2017-01-01)

TDP-43 Epigenetic Facets and Their Neurodegenerative Implications
by: Juliette Gimenez, et al.
Published: (2023-09-01)

Codon-optimized TDP-43 mediates neurodegeneration in a Drosophila model of ALS/FTLD
by: Tanzeen Yusuff, et al.
Published: (2023-03-01)

Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD Tauopathies
by: Marta del Campo, et al.
Published: (2021-10-01)

Progranulin Deficiency Induces Mitochondrial Dysfunction in Frontotemporal Lobar Degeneration with TDP-43 Inclusions
by: Guiomar Rodríguez-Periñán, et al.
Published: (2023-02-01)

TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration
by: Marina Buciuc, et al.
Published: (2022-01-01)

Restoring functional TDP-43 oligomers in ALS and laminopathic cellular models through baicalein-induced reconfiguration of TDP-43 aggregates
by: Hsiang-Yu Chang, et al.
Published: (2024-02-01)

Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43- ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology
by: Yi-Chao Lee, et al.
Published: (2018-11-01)

Mechanisms and models of TDP-43 proteinopathies
by: Petrucelli Leonard
Published: (2012-02-01)

Distinct molecular patterns of TDP-43 pathology in Alzheimer’s disease: relationship with clinical phenotypes
by: Sandra O. Tomé, et al.
Published: (2020-04-01)

Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72
by: Mauricio Budini, et al.
Published: (2017-05-01)

Environmental exposure to metals and the development of tauopathies, synucleinopathies, and TDP-43 proteinopathies: A systematic evidence map protocol
by: Kirstin Hester, et al.
Published: (2022-11-01)

Aberrant TDP‐43 phosphorylation: a key wind gap from TDP‐43 to TDP‐43 proteinopathy
by: Zi‐Qi Huang, et al.
Published: (2021-06-01)

The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
by: Britt A. Berning, et al.
Published: (2019-04-01)

Mechanisms of TDP-43 Proteinopathy Onset and Propagation
by: Han-Jou Chen, et al.
Published: (2021-06-01)

TDP-43 Proteinopathy Specific Biomarker Development
by: Isabell Cordts, et al.
Published: (2023-02-01)

Propagation of TDP-43 proteinopathy in neurodegenerative disorders
by: Rachel Keszycki, et al.
Published: (2022-01-01)

Sodium selenate as a therapeutic for tauopathies: A hypothesis paper
by: Roxane Dilcher, et al.
Published: (2022-08-01)

3′UTR Length-Dependent Control of SynGAP Isoform α2 mRNA by FUS and ELAV-like Proteins Promotes Dendritic Spine Maturation and Cognitive Function
by: Satoshi Yokoi, et al.
Published: (2017-09-01)

Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
by: Archana Prasad, et al.
Published: (2019-02-01)

TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy
by: Rachel Atkinson, et al.
Published: (2021-02-01)

Mitochondrion-Dependent Cell Death in TDP-43 Proteinopathies
by: Chantal B. Lucini, et al.
Published: (2021-04-01)

Heterogeneous Nuclear Ribonucleoprotein E2 (hnRNP E2) Is a Component of TDP-43 Aggregates Specifically in the A and C Pathological Subtypes of Frontotemporal Lobar Degeneration
by: Wejdan Kattuah, et al.
Published: (2019-06-01)

Understanding In Vitro Pathways to Drug Discovery for TDP-43 Proteinopathies
by: Hei W. A. Cheng, et al.
Published: (2022-11-01)

Incidence and morphology of secondary TDP-43 proteinopathies: Part 2
by: Albert Acewicz, et al.
Published: (2023-07-01)

Incidence and morphology of secondary TDP-43 proteinopathies: Part 1
by: Albert Acewicz, et al.
Published: (2022-11-01)

Functional implication of ubiquitinating and deubiquitinating mechanisms in TDP-43 proteinopathies
by: Non-Nuoc Tran, et al.
Published: (2022-09-01)

TDP-43 proteinopathy in Theiler's murine encephalomyelitis virus infection.
by: Katsuhisa Masaki, et al.
Published: (2019-02-01)

Pathological 25 kDa C-Terminal Fragments of TDP-43 Are Present in Lymphoblastoid Cell Lines and Extracellular Vesicles from Patients Affected by Frontotemporal Lobar Degeneration and Neuronal Ceroidolipofuscinosis Carrying a <i>GRN</i> Mutation
by: Sara Cimini, et al.
Published: (2022-11-01)